Related Experiment Videos
Cerebral glucose utilization in motor neuron disease
J M Hoffman1, J C Mazziotta, T C Hawk
1Division of Nuclear Medicine and Biophysics, UCLA School of Medicine.
Archives of Neurology
|August 1, 1992
Summary
Positron emission tomography (PET) revealed reduced cerebral glucose metabolism in motor neuron disease patients. While overall differences weren't significant, metabolism declined with motor weakness and upper motor neuron dysfunction.
Area of Science:
- Neuroscience
- Medical Imaging
Background:
- Motor neuron disease (MND) is characterized by selective motor neuron loss.
- This degeneration affects the motor cortex and corticospinal tract.
- The study investigates the relationship between neuronal loss and brain metabolism in MND.
Purpose of the Study:
- To examine regional cerebral glucose metabolism in individuals with motor neuron disease using 18F-fluorodeoxyglucose PET.
- To correlate metabolic changes with disease duration, severity, and neurological findings.
Main Methods:
- Positron emission tomography (PET) with 18F-fluorodeoxyglucose was employed.
- Regional cerebral glucose metabolism was assessed in patients with MND and age-matched controls.
- Metabolic data were analyzed for correlations with clinical parameters.
Main Results:
- Glucose metabolism was generally reduced in MND patients compared to controls, but not significantly after multiple comparison correction.
- No correlation was found between metabolism and disease duration or severity.
- A decline in glucose metabolism correlated with motor weakness and upper motor neuron dysfunction.
- Supplementary motor areas showed increased metabolism with disease progression, possibly indicating compensatory activity.
Conclusions:
- Cerebral glucose metabolism in MND shows complex regional changes.
- Metabolic decline is associated with motor deficits, suggesting a link to neuronal dysfunction.
- Increased metabolism in certain areas may reflect adaptive responses to neuronal loss.